EAHAD 2021 is underway and runs until February 5. Precision BioLogic and Affinity Biologicals are both presenting e-posters at the virtual event. Posters are also available for viewing and download from our websites:
Laboratory Validation of CRYOcheck™ Chromogenic Factor VIII Across Multiple Coagulation Analyzers, Precision BioLogic
Improved Recognition of B-Domain Deleted FVIII in Plasma with a New Commercially Available VisuLize™ F8Plus Antigen Kit, Affinity Biologicals
Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the U.S. launch of its new CRYOcheck™ Hex LA™ kit. Expansion to the U.S. follows successful launches in Canada, the European Union, Australia, and New Zealand.
CRYOcheck Hex LA is intended for use in clinical labs to aid in the detection of lupus anticoagulant (LA) in human plasma. Hex LA is an integrated (screen and confirm) assay and, as its name suggests, applies hexagonal phase phospholipids. It is the first commercially available hexagonal phase LA test available in a frozen format, allowing for fast and easy preparation. Designed to work on many common automated coagulation analyzers, Hex LA offers valuable time savings to today’s busy labs.
As we prepare to chill out, we extend wishes for a warm, relaxing holiday.
Please note, we are closed from December 23 to January 3. Our regular shipping schedule resumes when we reopen on January 4, 2021.
THSNA 2020 is underway. We're presenting three posters at this year's virtual conference:
Comparison of Hexagonal Phase Phospholipid Neutralization Assays for Lupus Anticoagulant Detection
CRYOcheck™ Chromogenic Factor VIII: A New Kit for the Determination of FVIII:C Activity
Precision BioLogic, a leading developer of hemostasis diagnostic products, is pleased to announce FDA 510(k) clearance and the launch of its new CRYOcheck Chromogenic Factor VIII assay in the U.S. This clearance follows authorizations received from regulatory authorities in Canada, the European Union, Australia, and New Zealand where the assay launched earlier this year.
Registration for the ISTH 2020 Virtual Conference, July 12 to 14, is now open and you can register for free!
We're presenting two scientific posters, which will be available on the ISTH 2020 Virtual Congress Platform starting July 12, 2020. Abstracts are now available online:
Effects of Anticoagulants and Common Interfering Substances on Four Commercially Available dRVVT Assays (Abstract Number: PB0669)
Laboratory Validation of a Novel Hexagonal Phase Phospholipid Neutralization Assay for Lupus Anticoagulant Detection (Abstract Number: PB0675)
Registration for the ISTH 2020 Virtual Conference, July 12 to 14, is now open. With the move to an online event, you can now register for free!
We're going to miss seeing you in person but hope you'll join online.
To learn more or register, visit: www.isth2020.org
Earlier this spring, we introduced a comprehensive webinar schedule to keep you up to date on all the latest developments at Precision BioLogic.
Our next webinar is "Frozen vs. Lyophilized: The Value of Precision" on Wednesday, June 3, 2020 from 1 to 2 pm Eastern. Sign up to learn more about this and future webinars.
In recognition of Lab Week and the selfless contributions of those working to protect us, Precision BioLogic and Affinity Biologicals have donated to the Canadian Red Cross and the CDC Foundation to assist in the fight against COVID-19.
As we adjust to recent developments caused by COVID-19, the safety of our customers and our personnel is our top priority.
While we'll miss seeing our customers in the foreseeable future, we've created a comprehensive webinar schedule to keep you up to date on all the latest developments at Precision BioLogic.
The first update is in late April with events continuing throughout the spring and summer.
Today is World Hemophilia Day—an international awareness day for hemophilia and other bleeding disorders. It's held each year on April 17, date of the birthday of Frank Schnabel, founder of the World Federation of Hemophilia (WFH).
This day also helps illustrate other WFH initiatives to support the bleeding disorders community. The WFH Humanitarian Aid Program provides a range of integrated care development training programs to ensure the local infrastructure and medical expertise are available to optimize and appropriately use donated products. The Global Alliance for Progress (GAP) Program was developed to greatly increase the diagnosis and treatment of people with bleeding disorders by closing the gap in treatment of people with bleeding disorders by closing the gap in treatment between developed and developing countries.
In response to the coronavirus (COVID-19), Precision BioLogic is acting to ensure the continuity of our product manufacturing and distribution along with our service levels. Ensuring the well-being of our employees is an important part of our response plan. Currently, we do not anticipate any significant disruptions. We are committed to delivering the quality products and services our customers have come to expect from us.
We continue to closely monitor the unfolding situation and will post updates on our website as they become available.
On January 23, Precision BioLogic was named Halifax’s Innovative Business of the Year at the 20th annual Halifax Business Awards.
The nomination and subsequent win recognize the 2019 launch of our CRYOcheck™ Factor VIII Inhibitor Kit along with our numerous poster publications and other educational activities to help labs deliver accurate results for the diagnosis and monitoring of FVIII inhibitors.
The award comes on the heels of the Canadian and EU launch of Precision BioLogic’s latest product, CRYOcheck™ Chromogenic Factor VIII.
